VP, Global Commercial Leader (Access & Marketing/Brand Leadership)
- Employer
- Intellia Therapeutics
- Location
- Cambridge, MA
- Start date
- Jul 9, 2024
View moreView less
- Discipline
- Marketing
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Genetown, Best Places to Work
Job Details
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How you will Achieve More with Intellia:
As a key member of the organization, you will lead the development and execution of commercial plans to support the potential launch of Intellia's late-stage pipeline of gene editing therapies. In this highly collaborative role, you will partner with Product Teams, Medical Affairs, New Product Planning, Legal, etc. to drive the planning and execution of strategies across Marketing, Brand, Pricing, Reimbursement, HEOR, Trade & Distribution, Patient Support Services, Market Access Marketing, Payer Management, Health Policy, and Key Account Strategy. The Global Commercial Leader is responsible for the following activities:
Market Access and HEOR:
Develop and support the execution of country-specific strategies for securing pricing, coverage, and reimbursement
Develop and support the execution of global pricing and contracting strategies that optimize access and value at the regional / country level
Establish effective distribution networks for pipeline products across target commercial markets
Oversee HEOR activities and drive HEOR strategies in support of achieving region-specific / country-specific reimbursement
Develop and execute patient support/reimbursement support programs tailored to target markets
Develop and execute innovative Market Access Marketing campaigns designed to communicate the value of Intellia Therapeutics products to Market Access customers (e.g., payers, key accounts, GPOs, etc.)
Develop and execute innovative and value-creating contracting strategies where such opportunities exist
Establish Intellia Therapeutics as a manufacturer credentialed to sell into target markets (e.g., establishing relevant U.S. federal and state markets pricing agreements)
Develop and execute U.S. market commercial payer engagement strategies both pre- (pre-approval information exchange) and post-FDA approval
Develop access strategies for target sites of care and centers of excellence in the U.S. market
Evaluate localized health policy and health care reform trends, assessing implications to the Intellia Therapeutics pipeline and portfolio
Collaborate with New Product Planning and early pipeline product teams to define global access critical success factors for target markets and patient populations, as necessary
Marketing and Leadership:
Lead or oversee the creation of the global brand plan and oversee the development and execution of the tactical plan in support of the overall brand strategy
Oversee pre-launch positioning and key message planning as well as post-launch tactical planning and implementation for Intellia’s pipeline products
Analyze key market trends and competitive environmental changes to drive proactive strategies that increase overall brand potential and awareness
Collaborate closely with key stakeholders such as investor relations, medical affairs, legal, and regulatory to develop and implement compelling messaging for various audiences
Stay ahead of and continuously monitor market dynamics, industry trends, and competitor activities
Conduct thorough market analysis and leverage KPIs to gain key insights into brand performance
Maintain and modify our global launch readiness playbook; bring creative thinking in go-to-market approaches
About You:
We are looking for candidates with deep experience (20+ years) in the healthcare industry whose background includes working with different rare diseases and gene therapy products.
Additional requirements include:
Strong relationships with members of the provider, patient, payer, and policy/government affairs community
A successful history of coordinating large projects with multiple stakeholders that have yielded tangible & high-quality results
An influential leader with a track record of building high-functioning teams
Experience with all aspects of the reimbursement life cycle; including early product development and commercialization of products globally
Evidence illustrating the ability to be different and bold. Must have demonstrated success at bringing novel and successful approaches that bring innovative products to patients
#LI-SV1
Covid-19 Vaccination Policy:All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Company
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.
Change life stories with genome editing therapies!
Stock Symbol: NTLA
- Website
- http://intelliatx.com/
- Phone
- (857) 285-6200
- Location
-
40 Erie Street
Cambridge
Massachusetts
02139
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert